Effectiveness of an Interprofessional Program (Siscare) for Supporting Patients With Type 2 Diabetes.


Journal

Diabetes spectrum : a publication of the American Diabetes Association
ISSN: 1040-9165
Titre abrégé: Diabetes Spectr
Pays: United States
ID NLM: 8913432

Informations de publication

Date de publication:
2023
Historique:
entrez: 23 2 2023
pubmed: 24 2 2023
medline: 24 2 2023
Statut: ppublish

Résumé

To assess the effectiveness of an interprofessional support program (Siscare) that includes motivational interviews (patient-pharmacist), electronic monitoring (EM) of medications, patient-reported and clinical outcomes monitoring, and interactions with physicians for patients with type 2 diabetes in French-speaking Switzerland. This was a prospective, multicenter, observational cohort study using a hybrid implementation-effectiveness design. Individual daily adherence to at least one oral antidiabetic medication was measured by EM. A global adherence score was estimated by the product of a model-estimated implementation and a nonparametric estimate of persistence over time. Clinical outcomes (A1C, blood glucose, BMI, blood pressure, heart rate, and cholesterol levels) and quality of life (QoL) were analyzed over time using linear mixed-effect models. A total of 212 patients were included from 27 pharmacies; 120 patients (57%) were followed up for at least 15 months. In total, 140 patients (66%) were male, the mean age was 64 ± 11 years, and the mean number of chronic medications per patient at baseline was 5 ± 3. Of 178 patients who used EM, 95% (95% CI 92-99%) remained persistent at the end of the follow-up period. The percentage of persistent patients taking their medications appropriately (implementation) was stable during follow-up and was estimated to be 90% (95% CI 87-92%) at baseline and 88% (95% CI 84-91%) at month 15. At baseline, the mean A1C and BMI were 7.5% and 31 kg/m The program supports medication adherence and improves clinical outcomes, illustrating the overall preventive effect of coordinated care.

Identifiants

pubmed: 36818412
doi: 10.2337/ds21-0084
pii: DS210084
pmc: PMC9935292
doi:

Banques de données

figshare
['10.2337/figshare.21385674']

Types de publication

Journal Article

Langues

eng

Pagination

41-51

Informations de copyright

© 2023 by the American Diabetes Association.

Déclaration de conflit d'intérêts

O.B. was a co-founder of Sispha SA and a member of the advisory board of Sispha SA. No other potential conflicts of interest relevant to this article were reported.

Références

Diabetes Metab Res Rev. 2002 Sep-Oct;18 Suppl 3:S64-9
pubmed: 12324988
Br J Clin Pharmacol. 2012 May;73(5):691-705
pubmed: 22486599
Med Care. 2005 Jun;43(6):521-30
pubmed: 15908846
Prim Care Diabetes. 2019 Jun;13(3):233-241
pubmed: 30583932
Diabetes Res Clin Pract. 2019 Nov;157:107843
pubmed: 31518657
Pharm World Sci. 2004 Feb;26(1):18-25
pubmed: 15018255
Medicine (Baltimore). 2016 Jun;95(26):e3994
pubmed: 27368004
Front Pharmacol. 2013 Jul 25;4:91
pubmed: 23898295
Prim Care Diabetes. 2008 Feb;2(1):31-7
pubmed: 18684418
J Clin Epidemiol. 2005 Feb;58(2):142-9
pubmed: 15680747
Diabet Med. 2015 Jun;32(6):725-37
pubmed: 25440507
Front Pharmacol. 2019 Jan 29;9:1567
pubmed: 30761009
BMC Health Serv Res. 2018 Nov 20;18(1):874
pubmed: 30458844
Am J Manag Care. 2005 Apr;11(4):253-60
pubmed: 15839185
Int J Clin Pharm. 2014 Feb;36(1):55-69
pubmed: 24166659
BMJ. 2008 Sep 29;337:a1655
pubmed: 18824488
J Clin Pharm Ther. 2011 Oct;36(5):602-13
pubmed: 21143256
Can J Diabetes. 2018 Apr;42 Suppl 1:S88-S103
pubmed: 29650116
Res Social Adm Pharm. 2021 Nov;17(11):1968-1977
pubmed: 33812807
Curr Med Res Opin. 2016 Jul;32(7):1243-52
pubmed: 26986190
Popul Health Manag. 2010 Oct;13(5):235-45
pubmed: 20879904
Circulation. 2019 Sep 10;140(11):e563-e595
pubmed: 30879339
Diabetes Technol Ther. 2012 Jul;14(7):630-4
pubmed: 22524548
PLoS One. 2019 Mar 12;14(3):e0213432
pubmed: 30861014
Pharm World Sci. 2010 Dec;32(6):776-86
pubmed: 20862544
Res Social Adm Pharm. 2019 Sep;15(9):1057-1067
pubmed: 30685443
Pharmacy (Basel). 2020 Jun 21;8(2):
pubmed: 32575887
Am J Med Qual. 2000 Jul-Aug;15(4):137-42
pubmed: 10948785
BMJ Open. 2018 Jan 21;8(1):e016982
pubmed: 29358417
BMC Health Serv Res. 2020 May 14;20(1):425
pubmed: 32410681
Qual Life Res. 1999;8(1-2):79-91
pubmed: 10457741
Diabetes Educ. 2016 Feb;42(1):34-71
pubmed: 26637240
Patient Educ Couns. 2011 Jun;83(3):288-94
pubmed: 21616627

Auteurs

Noura Bawab (N)

Community Pharmacy, Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.

Marie-Paule Schneider (MP)

Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, University of Lausanne, Geneva, Switzerland.
Medication Adherence and Interprofessionality Lab, School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland.

Pierluigi Ballabeni (P)

Department of Education, Research and Innovation, Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.

Isabella Locatelli (I)

Department of Education, Research and Innovation, Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.

Olivier Bugnon (O)

Community Pharmacy, Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.
Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, University of Lausanne, Geneva, Switzerland.
Community Pharmacy, School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland.

Clémence Perraudin (C)

Community Pharmacy, Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.

Classifications MeSH